Loading...
XSHE
000538
Market cap13bUSD
Oct 09, Last price  
51.40CNY
1D
1.00%
1Q
5.28%
Jan 2017
-32.50%
Name

Yunnan Baiyao Group Co Ltd

Chart & performance

D1W1MN
XSHE:000538 chart
P/E
17.80
P/S
2.23
EPS
2.89
Div yield, %
4.33%
Shrs. gr., 5y
-0.10%
Rev. gr., 5y
4.70%
Revenues
41.19b
+2.88%
3,200,335,5134,115,716,8995,723,198,6677,171,784,04310,075,437,83411,312,322,43213,815,242,06815,814,790,88018,814,366,37220,738,126,20522,410,654,40324,314,614,04327,016,914,50429,664,673,86832,742,767,00036,373,919,01536,488,372,64839,111,292,15540,033,300,81441,186,999,089
Net income
5.15b
+8.51%
272,181,326336,790,481465,420,155603,719,565926,168,5801,210,908,6661,582,845,7122,321,453,7932,506,076,5072,770,841,4112,919,876,8213,144,981,4323,493,771,5114,183,727,5565,516,072,0002,804,916,7263,001,125,8904,093,782,0814,749,415,5035,153,486,845
CFO
4.60b
+7.04%
292,162,70060,503,123806,896,878460,548,807432,083,8840794,948,911341,641,5861,586,864,1792,179,500,4012,984,757,6821,155,689,9481,549,034,3612,104,745,0003,828,906,6325,223,278,0003,209,410,0323,502,742,3394,297,003,1424,599,693,880
Dividend
Sep 24, 20261.038 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.

Key people

Jia Ma
Chief Financial Officer · since 2022
Tao He
Senior Vice President · since 2024
Shengli Li
Senior Vice President · since 2024
Shi Shen
Senior Vice President · since 2024
Ning Zhang
Chief Scientist · since 2022
Zhaoyun Zhu
TCM Strategy Scientist · since 2013
Yinghui Qian
Secretary of the Board · since 2022
Ming Dong
President, Chief Executive Officer, Vice Chairman of the Board · since 2024
Xin Guo
Director · since 2024
Ke Li
Director · since 2025
Changchuan Shangguan
Director · since 2024
Yunshan Xie
Director · since 2022
Guanghui You
Director · since 2024
Wenxue Zhang
Chairman of the Board · since 2024
Yangfeng Cao
Independent Director · since 2025
Yang Dai
Independent Director · since 2019
Guo'en Liu
Independent Director · since 2021
Chaohong Na
Independent Director · since 2025
Yongliang Zhang
Independent Director · since 2019
URL
https://www.yunnanbaiyao.com.cn
IPO date
Dec 15, 1993
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT